CLASSIFICATION OF MPN
The 2022 updated 5th edition of the World Health Organization Classification of myeloproliferative neoplasms and mastocytosis focused on changes in the rationale behind the classification, combined morphologic, immunophenotypic, molecular, and cytogenetic data that help to refine diagnostic criteria...
Saved in:
| Main Author: | Haifa Kathrin Al-Ali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001427 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Hen or the Egg: Inflammatory Aspects of Murine MPN Models
by: Jonas S. Jutzi, et al.
Published: (2015-01-01) -
Potential application of the bulk RNA sequencing in routine MPN clinics
by: Shenglong Li, et al.
Published: (2025-04-01) -
Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker
by: Fadul A, et al.
Published: (2024-12-01) -
Non-essential role of S100A9 in hematopoiesis in primary MPN and MDS mouse models
by: Qinglin Li, et al.
Published: (2025-07-01) -
Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report
by: Anthi Bouchla, et al.
Published: (2018-01-01)